Peripheral artery disease: vizsgálatok itt: Malajzia
3 trials · From ClinicalTrials.gov, checked 2026. november 15.. Ask the study team whether a trial fits you.
- 2/3. fázisTaking peopleCombined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Where
- Ipoh, Kota Kinabalu, Lembah Pantai, Pejabat Pakar, Perai, Perak
- Életkor
- 18 év and over
- People
- 3110 worldwide
- Run by
- CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00 - 4. fázisTaking peopleEfficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Buerger's Disease
- Where
- Kuala Lumpur
- Életkor
- 18 év to 65 év
- People
- 3
- Run by
- Cell Biopeutics Resources Sdn Bhd
See details and how to joinNCT05854615 - 4. fázisTaking peopleEfficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Peripheral Arterial Disease
- Where
- Kuala Lumpur
- Életkor
- 18 év to 65 év
- People
- 10
- Run by
- Cell Biopeutics Resources Sdn Bhd
See details and how to joinNCT05854641